Risk of HIV transmission under combined antiretroviral therapy: toward risk zero?

J Acquir Immune Defic Syndr. 2015 Mar 1;68(3):e41-2. doi: 10.1097/QAI.0000000000000471.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Retroviral Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active / methods*
  • Disease Transmission, Infectious / prevention & control*
  • Female
  • HIV Infections / drug therapy*
  • HIV Infections / transmission*
  • Humans
  • Male
  • Risk
  • Risk Assessment

Substances

  • Anti-Retroviral Agents